Stock A119610 INTEROJO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Interojo Inc.

Equities

A119610

KR7119610004

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-04-04 EDT 		5-day change 1st Jan Change
24,900 KRW -15.74% Intraday chart for Interojo Inc. -.--% -21.20%
05-16 Interojo Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-15 Interojo Inc.(KOSDAQ:A119610) dropped from S&P Global BMI Index CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The company returns high margins, thereby supporting business profitability.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Its low valuation, with P/E ratio at 8.71 and 7.23 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The opinion of analysts covering the stock has improved over the past four months.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
INTEROJO INC. Stock Interojo Inc.
-21.20% 225M -
ESSILORLUXOTTICA Stock EssilorLuxottica
+10.90% 97.81B
B
ALCON INC. Stock Alcon Inc.
+21.08% 43.89B
B
AUTEK CHINA INC. Stock Autek China Inc.
-31.13% 1.92B
D+
WARBY PARKER INC. Stock Warby Parker Inc.
+15.11% 1.91B
C+
PEGAVISION CORPORATION Stock Pegavision Corporation
+13.87% 1.19B -
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+71.95% 668M - -
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-9.21% 647M -
MENICON CO., LTD. Stock Menicon Co., Ltd.
-43.59% 624M
B-
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-46.44% 624M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. A119610 Stock
  4. Ratings Interojo Inc.